clinical trial · NCT03718039
Phase 2 Bunionectomy HTX-011 Administration Study
Postoperative PainHTX-011Luer Lock applicatorVial access deviceaprepitant
brief summary
This is a Phase 2, open-label, multi-cohort study to evaluate the analgesic efficacy, safety, and pharmacokinetics (PK) of a single, individualized dose of HTX-011 administered into the surgical site as a monotherapy or with other medications to enhance analgesia in subjects undergoing unilateral simple bunionectomy.
started
Oct 24, 2018
primary completion
Jan 31, 2019
completion
Mar 11, 2019
last updated
Mar 2, 2026
official title
A Phase 2 Open-Label Study of HTX-011 Via Individualized Dosing Administration for Postoperative Analgesia Following Unilateral Simple Bunionectomy
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol